Navigation Links
NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again
Date:5/5/2010

Unreliable lie detector readings result in innocent man spending 22 years in prison for murder; guilty man kills again.

Rochester, NY (PRWEB) May 5, 2010 -- National Association of Computer Voice Stress Analysts says it’s past time to reevaluate the polygraph’s role in criminal investigations. A recent WHEC.com story concerns what can only be described as one of the worst failures of the polygraph, a killer passed and an innocent man failed the polygraph during the murder investigation of 74-year-old Viola Manville in 1988. After failing the polygraph administered by the New York State Police, detectives were able to get the innocent man, Frank Sterling, to confess to the murder. Sterling was then convicted of Manville’s murder and sent to prison while her actual killer, Mark Christie, who passed the polygraph, also conducted by the New York State Police, went on to abduct and murder four-year-old Kali Ann Poulton. Christie was convicted of her murder and recently confessed to Manville’s murder. Frank Sterling was released from prison last week. If the polygraph had accurately identified Christie as the killer, little Kali Ann Poulton would still be alive and Frank Sterling would not have spent 22 years in prison for a crime that he did not commit.

This horrific case follows on the heels of the March 23, 2010 case where the murder of five Newark, NJ, teens in 1978 was solved by the recent confession of one of the killers, Lee Anthony Evans. Evans was the main suspect at the time of the initial investigation and took at least one polygraph test, which he passed. With no leads a
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NACVSA: Killer of Five Teenagers Passes Polygraph
2. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
3. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
4. DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger
5. NeoStem Appoints Deloitte & Touche as New Independent Registered Public Accounting Firm
6. ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
7. Spectral appoints two new board members
8. IGEN Networks appoints directors and provides business update
9. Enerkem appoints new Chief Financial Officer
10. Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development
11. Glycos Biotechnologies Appoints Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... RESEARCH TRIANGLE PARK, N.C. , June 1, ... FENCF), announced the presentation of positive interim results ... in SIOPEL6: A multi-centre open label randomised phase ... (STS) in reducing ototoxicity in patients receiving cisplatin ... data was presented at the American Society of ...
(Date:6/1/2015)... ROCHESTER, Minn. and SOUTH SAN ... Baxter Ventures, the venture arm of Baxter International Inc. ... Pharmaceutical Development, LLC ("VPD") today announced the formation of ... model initiated by Baxter Ventures to focus on the ... of immunology, hematology, and oncology. Following the spin-off of ...
(Date:6/1/2015)... BATON ROUGE, La. , June 1, 2015 /PRNewswire/ ... a Phase II trial of lead candidate EP-100 in ... targeted membrane-disrupting peptide designed to seek and destroy cancer ... their surfaces. LHRH receptors are over-expressed in a wide ... randomized, multi-center Phase II trial of EP-100 ...
(Date:6/1/2015)... 29, 2015 Research and Markets ... of the "2015 Strategies in European ... their offering. This new 273-page ... diagnostic market, including emerging tests, technologies, instrumentation, ... of leading suppliers. Companies Mentioned: ...
Breaking Biology Technology:Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 2Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 3Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 5Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... system, described as a breakthrough advancement in breast imaging, ... Drug Administration. , ,The system offers more evidence that ... tools that enable higher quality images for the detection ... GE Healthcare said the Senographe Essential system ...
... we asked William Yasnoff, founder of the eHealthTrust initiative, why ... that today are fractured and limited. , , ... William Yasnoff Yasnoff is a speaker at ... deliver a presentation titled "A New Patient-Centric and Sustainable Approach ...
... Madison, Wis. The Wisconsin Technology Council ... legislature with statewide membership arms, has announced eight additions ... have three-year terms and will join a board that ... business technology community. Electees include four technology organization leaders: ...
Cached Biology Technology:FDA approves advanced digital mammography system 2Interview: Dr. William Yasnoff on health records, part 2 2Interview: Dr. William Yasnoff on health records, part 2 3Interview: Dr. William Yasnoff on health records, part 2 4Interview: Dr. William Yasnoff on health records, part 2 5Interview: Dr. William Yasnoff on health records, part 2 6
(Date:5/18/2015)... , May 18, 2015 Fingerprint Cards ... FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if its ... until and including Q3 2015 and the sensors will be ... Communicated order values for 2015 hereby amount to 740 MSEK ... 2015 of 140 MSEK and a number of smaller orders ...
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS delegation ... had a strong showing at AUVSI,s Unmanned 2015 conference ... of Ohio,s UAS industry met with ... from all points along the UAS ecosystem. ... (DDC) Vice President for Aerospace Rich Knoll . "If ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... free. But we'd all agree it's not worthless. So, ... , In 1997, the University of Vermont's Robert Costanza ... per year in a now-famous paper in the journal ... services" has bloomed. This young discipline studies how nature--through ...
... developed the first-ever genomic test to predict which patients ... and which patients can avoid the toxic regimen of ... save thousands of lives each year by recommending chemotherapy ... the test's developers at Duke's Institute for Genome Sciences ...
... therapy extends average life expectancy and decreases recurrences of ... lung cancer, according to researchers at Rhode Island Hospital. ... seven years, the median survival rate at three years ... months when thermal ablation was followed by radiation for ...
Cached Biology News:What's nature worth? New computer models tell all 2First-ever genomic test predicts which lung cancer patients need chemotherapy to live 2First-ever genomic test predicts which lung cancer patients need chemotherapy to live 3First-ever genomic test predicts which lung cancer patients need chemotherapy to live 4Combined treatment extends life expectancy for lung cancer patients 2Combined treatment extends life expectancy for lung cancer patients 3